Medical Analysis Lab to Be Established in Coimbatore with Rs 29.67 Crore Investment

Jan 25, 2025

medical analysis lab, medical device testing, Coimbatore healthcare, IMQ Group, Indian healthcare sector
medical analysis lab, medical device testing, Coimbatore healthcare, IMQ Group, Indian healthcare sector

Share:

A state-of-the-art medical analysis laboratory, with an estimated cost of Rs 29.67 crore, will be established in Coimbatore. The initiative, supported by the Centre and state governments, aims to enhance the safety and efficiency of medical devices while creating job opportunities for analysts.

Key Highlights:
Objective:
The laboratory will be testing and verifying the safety and effectiveness of medical products and devices.

Economic Impact:
The plant is likely to create jobs for trained analysts and spur industrial development in the medical device industry.

Government Training Initiative:
Training sessions for drug inspectors would be organized in order to enhance their abilities and follow international standards.

IMQ Group’s Role:

  • European testing and inspection firm IMQ Group, through its joint venture Elettra Tech Labs Pvt Ltd (IMQ India), will provide state-of-the-art services in the inspection and testing of medical devices.

  • IMQ India will be managed by CEO Stefano Ferretti and COO Kiran Raju Narayan.

Expansion Plans:
IMQ Group seeks to focus on the medical device industry and venture into next-generation test technologies in support of India's drive towards innovation and sustainability.

Strategic Growth:
The program is in line with India's Production Linked Incentive (PLI) Scheme, further establishing the nation as an international hub for electronics and medical devices.

Statements from Leaders:
M N Sridhar, Director of Drugs Control and Controlling Authority:
"This lab will not only guarantee the safety and effectiveness of medical devices but also create employment opportunities for analysts and improve skill sets through government training programs for drug inspectors.

"Vincenzo de Martino, IMQ Group President and CEO:
"Through IMQ India, we want to provide world-class testing services while promoting local expertise and propelling market development in the medical device industry."The setting up of the medical analysis laboratory in Coimbatore is a landmark for India's medical device industry. It has the potential to drive innovation, foster skilled jobs, and reinforce India's position on the global landscape of medical and electronic device production.

medical analysis lab
medical device testing
Coimbatore healthcare
IMQ Group
Indian healthcare sector
medical analysis lab
medical device testing
Coimbatore healthcare
IMQ Group
Indian healthcare sector

Medical Analysis Lab to Be Established in Coimbatore with Rs 29.67 Crore Investment

Jan 25, 2025

medical analysis lab, medical device testing, Coimbatore healthcare, IMQ Group, Indian healthcare sector
medical analysis lab, medical device testing, Coimbatore healthcare, IMQ Group, Indian healthcare sector

A state-of-the-art medical analysis laboratory, with an estimated cost of Rs 29.67 crore, will be established in Coimbatore. The initiative, supported by the Centre and state governments, aims to enhance the safety and efficiency of medical devices while creating job opportunities for analysts.

Key Highlights:
Objective:
The laboratory will be testing and verifying the safety and effectiveness of medical products and devices.

Economic Impact:
The plant is likely to create jobs for trained analysts and spur industrial development in the medical device industry.

Government Training Initiative:
Training sessions for drug inspectors would be organized in order to enhance their abilities and follow international standards.

IMQ Group’s Role:

  • European testing and inspection firm IMQ Group, through its joint venture Elettra Tech Labs Pvt Ltd (IMQ India), will provide state-of-the-art services in the inspection and testing of medical devices.

  • IMQ India will be managed by CEO Stefano Ferretti and COO Kiran Raju Narayan.

Expansion Plans:
IMQ Group seeks to focus on the medical device industry and venture into next-generation test technologies in support of India's drive towards innovation and sustainability.

Strategic Growth:
The program is in line with India's Production Linked Incentive (PLI) Scheme, further establishing the nation as an international hub for electronics and medical devices.

Statements from Leaders:
M N Sridhar, Director of Drugs Control and Controlling Authority:
"This lab will not only guarantee the safety and effectiveness of medical devices but also create employment opportunities for analysts and improve skill sets through government training programs for drug inspectors.

"Vincenzo de Martino, IMQ Group President and CEO:
"Through IMQ India, we want to provide world-class testing services while promoting local expertise and propelling market development in the medical device industry."The setting up of the medical analysis laboratory in Coimbatore is a landmark for India's medical device industry. It has the potential to drive innovation, foster skilled jobs, and reinforce India's position on the global landscape of medical and electronic device production.

Share:

medical analysis lab
medical device testing
Coimbatore healthcare
IMQ Group
Indian healthcare sector
medical analysis lab
medical device testing
Coimbatore healthcare
IMQ Group
Indian healthcare sector